Special Meeting Report, April 27th 2023 Click here for NZSA Assessment and Voting intentions This meeting was called to consider a revised offer of NZ$1.42 per share from Pegasus Bidco Limited a company that will be ultimately owned by the Sixth Street and BGH Capital Consortium. Sixth Street is the largest shareholder with 20% of…
Read more
Annual Meeting Report, April 26th 2023 Click here for NZSA Assessment and Voting intentions Metric 2020 2021 2022 Change Revenue $335.2m $365.6m $365.6 0% EBITDA $60.9m $52.5m $64.2m 22% NPAT $14.2m $34.4m $22.7m -34% EPS1 $0.072 $0.174 $0.115 -34% PE Ratio 19 5 10 Capitalisation $288m $217m -25% Current Ratio 0.93 0.87 0.92 6% Debt…
Read more
Special Meeting Report, April 21st 2023 Click here for NZSA Assessment and Voting intentions MHM operates under five brands: The resolutions before the meeting effectively provided for a merger of MHM and Wyma Engineering (NZ) Limited. Wyma is a Christchurch based company that designs and supplies post-harvest solutions for the vegetable and fruit handling sectors. …
Read more
Annual Meeting Report, April 19th 2022 Click here for NZSA Assessment and Voting intentions Metric 2020 2021 2022 Change Revenue $78.4m $88.0m $95.7m 9% EBITDA $34.4m $34.4m $35.1m 2% NPAT $17.6m $15.0m $14.2m -6% EPS1 $0.063 $0.053 $0.045 -16% PE Ratio 31 26 27 Capitalisation $546m $396m $384m -3% Current Ratio 1.29 1.61 0.85 24%…
Read more
Annual Meeting Report, March 29th 2023 Click here for NZSA Assessment and Voting intentions Metric 2020 2021 2022 Change Operating Revenue $97.4m $108.6m $110.9m 2% Fair value adjustment $72.5m $392.5m -$56.7m n/a Total Income $176.1m $517.2m $73.3m -86% EBITDA $135.7m $472.8m -$6.5m n/a NPAT $113.4m $452.8m -$13.9m n/a EPS1 $0.224 $0.896 -$0.028 n/a Capitalisation $1,412m…
Read more
Annual Meeting Report, February 28th 2023 Click here for NZSA Assessment and Voting intentions Metric 2021 2022 (re-presented) 2023 Change Revenue $315.3m $327.9m $352.1m 7% Underwriting Profit $30.3m $22.5m $23.6m 5% NPAT2 $10.8m $19.3m $17.6m -6% EPS1 $0.027 $0.046 $0.047 2% PE Ratio 27 15 15 Capitalisation $286.7m $261.8m -9% Current Ratio 1.57 1.57 1.37…
Read more
Annual Meeting Report, February 23rd 2023 Click here for NZSA Assessment and Voting intentions Metric 2020 2021 2022 Change Revenue $100.6m $105.7m $126.3m 19% Operating Expense $93m $118.2m 27% EBITDA $12.1m $12.7m $8.1m -36% NPAT -$31.7m $3.2m -$3.3m n/a EPS1 -$0.321 $0.032 -$0.033 n/a PE Ratio n/a 54 n/a Current Ratio 1.28 1.53 1.56 2%…
Read more
First published in The Briefing (Feb 20th 2023) It’s been the beginning of redemption for Ryman Healthcare this week. Redemption is in the form of a long-expected capital raise, Ryman’s first since listing, with the aim of reducing it’s significant debt burden and strengthening the company’s balance sheet. We’re pleased to see that the company…
Read more
This article is written by Dr. Denis Mowbray, and originally appeared as a paper within the Chartered Governance Institute in June 2021. It is re-published here with the author’s permission. It neatly encapsulates NZSA’s core assumptions relating to the role of board members, executives and their combined impact on corporate performance. Why is it that…
Read more
NZSA is pleased to bring you the 2023 Investor Conference – especially welcome after the Covid-related impacts on our events since 2019. We hope you make the most of the opportunity to gain insight from the amazing array of speakers we have brought together. Our Changing World NZSA believes that this is a theme that…
Read more
